No Data
Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
The Past Five Years for Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Investors Has Not Been Profitable
Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
With a 39% Stake, Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Insiders Have a Lot Riding on the Company
Chengdu Kanghong Pharmaceutical Group (002773.SZ): Vice President Ni Jing resigned for personal reasons.
Gelonghui, December 17: Chengdu Kanghong Pharmaceutical Group (002773.SZ) announced that the company's Board of Directors recently received a written resignation letter from Ms. Ni Jing, the company's Vice President. Ms. Ni Jing has applied to resign from her position as Vice President due to personal reasons. After her resignation, Ms. Ni Jing will no longer hold any positions in the company or its subsidiaries.
Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Shares Fly 25% But Investors Aren't Buying For Growth
